Logo
C

Celeris Therapeutics

17 employees

Harnessing deep learning and lab automation to accelerate drug discovery in targeted protein degradation.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
Artificial Intelligence
Graph Neural Networks
Life Science
Drug Design
Drug Discovery
PPI
Deep Learning
Protein
Geometric Deep Learning
Information Technology
Molecular glue
PROTAC
Protein-Ligand Interaction
Drug Builder
Protein-Protein-Interaction

Date founded

2021

Funding rounds raised

Total raised

$3.4M

from 6 investors over 6 rounds

C

Celeris Therapeutics raised $3.4M on February 10, 2022

Investors: Pace Ventures, i&i Prague, Longevitytech.fund and R42 Group

C

Celeris Therapeutics raised $471K on March 28, 2021

Investors: Longevitytech.fund and R42 Group

FAQ